Skip to main content

Table 5 miRNA Selection (IG and CFS) based on Consensus p-Median on the Liu dataset

From: A p-Median approach for predicting drug response in tumour cells

IG

 

CFS

miRNA

Target gene

miRNA

Target gene

hsa-miR-200a

AP3S1

hsa-miR-196b

HOXA7

hsa-miR-429

ZEB2

hsa-miR-18b

OTX2

hsa-miR-200b

ZEB2

hsa-miR-142-5p

SGPP1

hsa-miR-200c

ZEB2

hsa-miR-100

TMPRSS13

hsa-miR-141

AP3S1

hsa-miR-106a

DYNC1LI2

hsa-miR-196b

HOXA7

hsa-miR-145

FAM108C1

hsa-miR-18b

OTX2

hsa-miR-17*

HMGA2

hsa-miR-100

TMPRSS13

hsa-miR-376c

PAX4

hsa-miR-365

ZNF680

hsa-miR-211

ACSM2A

hsa-miR-494

ARID4B

hsa-miR-503

MYH10

  1. The reported miRNAs refer to the outperforming BNs (84.22% of accuracy with IG and 84.12% with CFS): for IG the optimal BN is denoted by Consensus p-Median (g-d) with μ=1.6, while for CFS the optimal BN is obtained by means of Consensus p-Median (d-g) with μ=2.1. miRNAs belonging the “microRNA in cancer” pathway are marked as bold.